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Abstract
One of the hallmarks of HIV-1 disease is the association of heightened CD4+ T-cell activa-
tion with HIV-1 replication. Parasitic helminths including filarial nematodes have evolved
numerous and complex mechanisms to skew, dampen and evade human immune
responses suggesting that HIV-1 infection may be modulated in co-infected individuals.
Here we studied the effects of two filarial nematode products, adult worm antigen from Bru-
gia malayi (BmA) and excretory-secretory product 62 (ES-62) from Acanthocheilonema
viteae on HIV-1 infection in vitro. Neither BmA nor ES-62 influenced HIV-1 replication in
CD4+ enriched T-cells, with either a CCR5- or CXCR4-using virus. BmA, but not ES-62, had
the capacity to bind the C-type lectin dendritic cell-specific intercellular adhesion molecule-
3-grabbing non-integrin (DC-SIGN) thereby inhibiting HIV-1 trans-infection of CD4+
enriched T-cells. As for their effect on DCs, neither BmA nor ES-62 could enhance or inhibit
DC maturation as determined by CD83, CD86 and HLA-DR expression, or the production of
IL-6, IL-10, IL-12 and TNF-α. As expected, due to the unaltered DC phenotype, no differ-
ences were found in CD4+ T helper (Th) cell phenotypes induced by DCs treated with either
BmA or ES-62. Moreover, the HIV-1 susceptibility of the Th-cell populations induced by
BmA or ES-62 exposed DCs was unaffected for both CCR5- and CXCR4-using HIV-1
viruses. In conclusion, although BmA has the potential capacity to interfere with HIV-1 trans-
mission or initial viral dissemination through preventing the virus from interacting with DCs,
no differences in the Th-cell polarizing capacity of DCs exposed to BmA or ES-62 were
observed. Neither antigenic source demonstrated beneficial or detrimental effects on the
HIV-1 susceptibility of CD4+ Th-cells induced by exposed DCs.
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Introduction
Human immunodeficiency virus type 1 (HIV-1) is endemic in many regions of the world
where individuals are infected with an array of pathogens [1]. Parasitic helminths infect large
numbers of the population and are known to evade, skew and dampen immune responses
thereby potentially having consequences for HIV-1 disease, as continuous immune system acti-
vation is one of the driving factors in HIV-1 infection and disease course [2]. Worldwide over
120 million people are infected with filarial nematodes, which can survive for decades within
locations such as our lymphatic system and can cause high levels of morbidity [3,4]. How para-
sites and parasite antigens modulate HIV-1 infection, and vice versa, is relatively unknown but
will have significance in regions where co-infection rates are high.
HIV-1 cell entry is facilitated by the gp120 envelope protein, which binds to its primary
receptor CD4 and subsequently to a co-receptor, usually CCR5 or CXCR4 [5,6]. Direct infec-
tion of cells via these receptors is termed cis-infection. Additionally, gp120 can bind several C-
type lectin receptors (CLR) on cells derived from the myeloid cell lineage. These cells can sub-
sequently pass the virion to activated CD4+ T-lymphocytes, a process termed trans-infection
[7]. Dendritic cell-specific intercellular adhesion molecule-3-grabbing non-integrin (DC-
SIGN) is a CLR expressed on dendritic cells (DCs) known to support HIV-1 trans-infection
and has been implicated in HIV-1 transmission and dissemination [7,8]. In addition to gp120,
DC-SIGN can bind many glycosylated structures including a large array of pathogen-derived
glycoproteins as well as numerous host proteins found in bodily secretions. Binding of these
glycoproteins to DC-SIGN can actually block its ability to capture and transfer HIV-1 [9–12].
The main target cells for HIV-1 are CD4+ effector memory T-cells, also known as the T
helper (Th) cells. Th-cells are subdivided based on their cytokine expression profile into three
main types of effector Th-cells namely Th1, Th2 and Th17 cells which are induced by intracel-
lular pathogens (e.g. viruses), parasites and bacterial or fungal infections, respectively [13]. The
balance between HIV-1 co-receptor expression and production of their natural ligands, MIP-
1α, MIP-1β and RANTES for CCR5, and SDF-1 for CXCR4 has been shown to be important in
determining T-cell susceptibility to HIV-1 infection [14–16]. More recent studies have corre-
lated pathogen-specific CD4+ T-cells to HIV-1 susceptibility [17–19]. Geldmacher et al corre-
lated variation in HIV-1 susceptibility with a difference in the cytokine/chemokine profile of
CD4+ T-cells. They demonstrated thatMycobacterium tuberculosis specific-CD4+ T-cells, lost
rapidly after HIV-1 infection, express high levels of IL-2 and low levels of MIP-1β contrary to
the CMV specific CD4+ T-cells, which possess the reverse profile and typically survive until
end stage AIDS [17]. Besides cytokines, heightened levels of T-cell activation have been associ-
ated with the up regulation of numerous HIV-1 restriction factors thereby potentially modulat-
ing cellular infection profiles [20].
Parasitic helminths are known for their capacity to induce T-cell responses with a Th2 phe-
notype. In previous studies soluble egg antigen from Schistosoma mansoni has been shown to
skew CD4+ T-cell responses in such a direction, potentially through its capacity to bind CLRs
present on the surface of DCs [21–23]. Whereas S.mansoni is quite well studied, far less is
known about the effect of filarial nematodes on cells of the human immune system. Lymphatic
filariasis is caused byWuchereria bancrofti, Brugia malayi and Brugia timori [3]. B.malayi. is
found in South East Asia and has several life-cycle stages in the human host, L3 larvae, L4 lar-
vae, adult worms and their offspring microfilaria (mf) L1 larvae [3]. Each of the developmental
stages has a unique set of immunological characteristics [3,24,25] and it is the adult worm,
especially the female, which is capable of skewing T-cell responses towards a Th2 phenotype
[26]. The exact mechanism by which B.malayi skews the immune system is still unknown
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although the presence of phosphorylcholine (PC) groups on molecules derived from filarial
nematodes seems to play an important role.
The most studied PC-containing component from a filarial nematode is the excretory secre-
tory protein 62 (ES-62) from the rodent filarial nematode Acanthocheilonema viteae. A 77%
homologous molecule has been shown to be secreted by adult B.malayi parasites [27,28]. ES-
62, alternatively known as leucylamino peptidates (LAP), possesses a range of immunomodula-
tory activities [29,30]. Firstly, it has been shown to interfere with signaling through the T-cell
and B-cell receptors rendering cells unresponsive to subsequent antigen activation [29,31,32].
Secondly, ES-62 can also interact with TLR4 thereby inhibiting MyD88-mediated signaling
and prevent subsequent TLR4 signaling [33]. Thirdly, ES-62 has been shown to promote a Th2
cell-inducing phenotype in murine macrophages and DCs [34,35]. Fourthly, ES-62 has been
demonstrated to induce Th2 rather than Th1 cell responses in vivo based on the antibody
responses that were skewed towards IgG1 [36,37]. And lastly, ES-62 has been shown to have
beneficial effects on the outcome of autoimmune diseases such as asthma, arthritis and lupus
in mouse model systems [38–40]. Although there is very limited data on the effect of ES-62 on
human cells, mast cells and Jurkat T-cells have been studied, ES-62 clearly modulated their
responses to certain stimuli [29,41]. The active component of ES-62 has been identified as PC
which is covalently attached to a N-linked glycan [36,42–44]. The ES-62 homologue secreted
by adult B.malayi is however not the main PC-carrying molecule, here N-acetyl glycosaminyl-
transferase also secreted by the adult worm has the highest PC content [28].
Here we studied the effect of BmA and ES-62 on HIV-1 cis- and trans-infection. Addition-
ally, we examined whether exposing DCs to BmA and ES-62 resulted in modulated maturation,
Th-cell induction or the susceptibility of the induced Th-cells to HIV-1 infection.
Materials and Methods
Parasitic products
Adult Brugia malayi worms were purchased from TRS labs (Athens, Georgia, USA). B.malayi
adult worm extract (BmA) was prepared by homogenization of adult male and female worms
on ice in PBS containing 0.5% n-octyl glucoside (PBS-nOG). The homogenates were centri-
fuged at 12,000 g, and the insoluble pellet was extracted once more with PBS-nOG to remove
any remaining soluble antigen. The supernatants were pooled and passed through a 0.45 mm
filter with the protein concentration determined using the Bradford method. The BmA total
protein extract was aliquoted and stored at -70°C until use at the desired concentration. Highly
purified, endotoxin-free ES-62 was prepared essentially as previously described [45].
Viruses
The HIV-1 subtype B replication competent viruses SF162 (R5) and LAI (X4) were used.
SF162 is a CCR5 using virus which is a molecular cloned isolate obtained from an HIV-1
infected patient. The CXCR4 using virus LAI also represents a molecular cloned virus isolated
from an HIV-1 infected patient. Viruses were passaged on CD4 enriched T-cells and tissue cul-
ture infectious dose (TCID50) values were determined by limiting dilutions on these cells
according to the Reed and Muench method [46].
ELISA’s
The DC-SIGN binding ELISA was performed as described [12]. In short, BmA (25μg/ml) or
ES-62 (8μg/ml) were coated on an ELISA plate followed by addition of 333ng/ml DC-SIGN-Fc
(R&D systems). Next, a secondary goat-anti-human-Fc HRP labelled antibody (1:1000,
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Jackson Immunology) was used to detect DC-SIGN-Fc bound to the plate. In the gp140 com-
petition ELISA, 10μg/ml anti-HIV-1 gp120 antibody D7324 (Aalto BioReagents Ltd) was
coated on an ELISA plate after which trimeric HIV-1 gp140 (JR-FL SOSIP.R6-IZ-D7324) was
added, as previously described [47,48]. Meanwhile 333ng/ml DC-SIGN-Fc (R&D systems) was
incubated with BmA (50μg/ml), subsequently the mixture was added to the gp140 coated plate.
Using a secondary HRP labelled goat-anti-human-Fc antibody (Jackson Immunology)
(1:1000), DC-SIGN-Fc—gp140 binding was determined [48]. The Capsid p24 ELISA was per-
formed as standard [10]. In short, culture supernatant was added to an ELISA plate coated
with 10μg/ml sheep anti-p24-specific antibody (Aalto Bio Reagents Ltd.). Next, 4ng/ml mouse
anti-HIV-1-p24 alkaline phosphatase conjugate antibody (Aalto Bio Reagents Ltd.) was added
followed by Lumi-phos plus (Lumigen Inc.) (development solution) according to the manufac-
turer's protocol. A serial dilution of Escherichia coli-expressed recombinant HIV-1-p24 (Aalto
Bio Reagents Ltd.) functioned as the standard curve.
Cytokine concentrations were determined using a standard ELISA protocol and the follow-
ing antibody pairs IL6 (CD205-c 1:200 and CD205-d 1:200, U-CyTech), IL10 (JES3-9D7 1:1000
and JES3-12G8 1:1000, BD Pharmingen), IL12 (20C2 1: 500 and C8.6 1:2000, own cultures)
and TNF-α (MAb1 1:500 and MAb11 1:250, eBioscience).
Cell lines and primary cell isolation
Raji DC-SIGN cells were cultured in RPMI 1640 (Invitrogen) supplemented with 10% FCS,
100U/ml penicillin and 100U/ml streptomycin (100U/ml Pen/ Strep). Peripheral blood mono-
nuclear cells (PBMCs) were isolated from buffy coats (purchased Sanquin) obtained from
healthy volunteers using ficoll-hypaque density centrifugation. PBMCs of 3 CCR5 wild-type
homozygous donors were pooled and cultured in RPMI 1640 containing 10% FCS, 100U/ml
Pen/ Strep, 100U/ml recombinant IL-2 (Chiron), and 2μg/ml phytohemagglutinin (PHA,
Remel) was used to activate the cells. After 5 days of culture PBMCs were enriched for CD4+
T-cells by depleting the CD8+ T-cell population using CD8 dynabeads (Life Technologies)
according to manufacturer’s protocol. Monocytes were isolated from PBMC as previously
described [49]. Monocytes cultured in IMDM (Gibco) containing 5% FCS, 86μg/ml gentamy-
cin (Duchefa), 500U/ml GM-CSF (Schering-Plough) and 10U/ml IL-4 (Miltenyi Biotec) for 6
days differentiated into immature DCs (iDCs). The CD4+ T-cell isolation MACS kit (Miltenyi
Biotec, 130-091-155) was used according to manufacturer’s protocol to isolate CD4+ T-cells
from the PBL fraction. Subsequently, the CD4+CD45RA+CD45RO- naïve T-cells were isolated
from the CD4+ T-cells using anti-CD45RO-PE (DAKO, R084301) and anti-PE beads (Milte-
nyi-Biotec, 130-048-801), described in detail [49].
HIV-1 cis- infection
CD4+ enriched T-cells (2x105 cells/well) were incubated with 25, 5 or 1μg/ml BmA, 4, 2, 1μg/
ml ES-62 or medium (control) 2h prior to and during HIV-1 infection. HIV-1 SF-162
(TCID50/ml 1000) or LAI (X4) (TCID50/ml 200) was added and 4, 7 and 12 days post-infection
HIV-1 Capsid p24 was determined in the supernatant by ELISA. Neither antigen source was
shown to be toxic for iDCs (S1 Fig).
HIV-1 trans-infection assay
Raji DC-SIGN cells (2x104 cells/well) were pre-incubated for 2h with 5μg/ml BmA after which
SF162 (R5) (TCID50/ml 5000) or LAI (X4) (TCID50/ml 2500) was added for an additional 2h.
Subsequently, the cells were washed 3 times and co-cultured with 2x105 cells/well CD4+-
enriched T-cells. 4, 7 and 12 days post-infection viral outgrowth was measured by determining
Effects of Filarial Nematode Antigens on HIV-1 Infection
PLOS ONE | DOI:10.1371/journal.pone.0146527 January 25, 2016 4 / 18
the supernatant Capsid p24 levels (using the p24 ELISA). HIV-1 capture/transfer by iDCs was
conducted with minor modifications as to the protocol described above, where BmA antigen
was tested at 500μg/ml and where the incubation period was shortened to 0.5h. These adapta-
tions were made due to the high expression levels of DC-SIGN on iDCs and rapid receptor
turnover at the cell surface.
Assessment of DC maturation
Between 25-40x103 iDCs were cultured in a 96 well plate with 1, 2 or 4μg/ml ES-62 or 10, 25 or
75μg/ml BmA in the presence of 1.0 or 100ng/ml LPS for 24h. The supernatant was stored at
-20°C and the IL-6, IL-10, IL-12 and TNF-α concentrations determined by ELISA. 40x104
monocytes were cultured (24 well plate) in IMDM containing 5% FCS, 86μg/ml gentamycin
(Duchefa), 500U/ml GM-CSF (Schering-Plough) and 10U/ml IL-4 (Miltenyi Biotec). After 6
days monocytes had differentiated into iDCs and half of the medium was replaced with
medium containing 1, 2 or 4μg/ml ES-62 or 10, 25 or 75μg/ml BmA in the presence of 1.0 or
100ng/ml LPS and where 48h later the cells were FACS-analysed for CD86, CD83 and
HLA-DR expression.
DC-T-cell outgrowth model system
Donor A iDCs were matured with 100ng/ml LPS (Sigma Aldrich) or 100ng/ml LPS and 10μM
PgE2 (Sigma Aldrich) in the absence or presence of 25μg/ml BmA or 2–4μg/ml ES-62.
Matured DCs were washed 3 times, subsequently 5x103 cells were co-cultured with 2x104
CD4+CD45RA+CD45RO- T-cells from donor B and 10pg/ml Staphylococcus enterotoxin B
(Sigma-Aldrich) in IMDM, 10% FCS, 86μg/ml gentamycin (Duchefa). At day 5 and 7 the cells
were split and the medium was supplemented with 20U/ml IL-2. At day 8, 5x104 cells/well
were plated and infected with SF162 (R5) (TCID50/ml 1000) or LAI (X4) (TCID50/ml 200).
Cells were re-stimulated with 10ng/ml PMA (Sigma-Aldrich), 1μg/ml ionomycin (Sigma-
Aldrich), 10μg/ml brefeldin A (Sigma-Aldrich) and 0.1μg/ml T1294 (Pepscan Therapeutics
BV) for 6h day 5 and 7 post-infection. Subsequently, the cells were fixed in 3.7% formaldehyde
and stored for no more than 1 week at 4°C in FACS buffer (PBS+ 2%FCS) for flow cytometry
analysis. CD4+ T-cells are the major cell type being analysed here since the culture conditions
used are non-permissive for iDC survival. HIV-1 infection is determined at the optimal time-
point which varies between donor and virus and where cell viability is high (>50%).
Flow cytometry
To determine CD86, CD83 and HLA-DR on DCs the cells were washed twice using FACS
buffer and were subsequently stained using CD86-PE (IT2.2, BD Biosciences), CD83-APC
(HB15e, Biolegend) and HLA-DR-PerCp (L243, BD Biosciences) for 30min at 4°C in FACS
buffer. Cells were washed once more with FACS buffer and were analysed on a FACS Canto II
apparatus. To assess the capacity of T-cells to produce cytokines/ chemokines, cells were per-
meabilized with PermWash (BD Pharmingen) according to manufacturer’s protocol to stain
for intracellular markers. Cells were stained for p24-RD1 (Beckman Coulter, KC57-RD1) and
IFN-γ-FitC (4S.B3), IL2-PerCp-Cy5.5 (MQ1-17H12), IL-4-APC (MP4-25D2), TNF-α-
PE-CF594 (MAb11), Mip-1β-AlexaFluor700 (D21-1351) (all from BD Bioscience) for 30min
at 4°C in PermWash. Next, these cells were washed once with PermWash, resuspended in
FACS buffer (PBS+ 2%FCS) and measured on a FACS Canto II apparatus. The histograms
depict all T-cells capable of producing a certain cytokine/ chemokine at the optimal time point.
The optimal time point was determined by the percentage of live cells (>50%) and the level of
HIV-1 infection, which varied per donor and per virus between day 5 and 7.
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Statistics
The unpaired student T tests were used except in figures demonstrating relative levels of infec-
tion. Here the paired student T test was utilized.
Results
BmA but not ES-62 blocks HIV-1 trans-infection of CD4+ T-lymphocytes
Previous studies have shown that an array of pathogen-derived glycoproteins bind DC-SIGN
[9]. Here we assessed whether the filarial nematode derived products BmA and ES-62 had simi-
lar properties in binding this specific CLR. First we examined their potential to modulate HIV-
1 cis-infection of CD4+ enriched T-cell blasts (CD8+ depleted T-cell blasts). These cells were
incubated with 1, 5 or 25μg/ml BmA after which the CCR5-using HIV-1 virus SF162 or the
CXCR4-using virus LAI was added. Viral outgrowth of SF162 (R5) and LAI (X4), determined
by the presence of HIV-1 capsid protein (p24) in the supernatant, was unaffected by the pres-
ence of BmA (Fig 1A). Similarly, SF162 (R5) and LAI (X4) outgrowth in CD4+ enriched T-cells
exposed to 1, 2 or 4μg/ml ES-62 was also unaffected (Fig 1B). This demonstrates that neither
BmA nor ES-62 has the capacity to prevent HIV-1 binding to CD4, CCR5 or CXCR4.
Next we assessed the capacity of BmA and ES-62 to bind DC-SIGN, which plays a promi-
nent role in HIV-1 trans-infection. Utilizing a DC-SIGN binding ELISA we found that
DC-SIGN-Fc bound dose-dependently to increasing concentrations of BmA (Fig 1C) whilst
DC-SIGN-Fc did not bind to ES-62 (data not shown). To gain insight into the potential of
BmA to prevent HIV-1 trans-infection we performed a gp140 competition ELISA in which
trimeric gp140, mimicking HIV-1’s natural envelope protein, is coated to a plate after which
DC-SIGN-Fc pre-incubated with BmA was added. Limiting dilutions of BmA demonstrated
a dose-dependent inhibition of DC-SIGN-Fc binding to the gp140 coated plate, although to a
lesser extent than mannan which potently binds DC-SIGN and inhibit HIV-1 capture
(Fig 1D).
To address whether BmA is capable of preventing HIV-1 trans-infection at the cellular level
Raji DC-SIGN cells were incubated with BmA prior to addition of HIV-1 SF162 (R5) or LAI
(X4). Viral outgrowth of both viruses in Raji DC-SIGN-CD4+-enriched T-cell blast co-cultures
was significantly reduced (p = 0.033 and p = 0.012, respectively) when Raji DC-SIGN cells
were pre-incubated with 5μg/ml BmA, indicating that BmA can block HIV-1 trans-infection
(Fig 1E). Similarly, when testing iDCs from three different donors with a high concentration of
BmA (500μg/ml) we found 100% inhibition in all three donors of HIV-1 capture and transfer
(Fig 1F). In conclusion, neither BmA nor ES-62 can block cis-infection of CD4 enriched T-cells
while BmA can bind DC-SIGN and block HIV-1 capture and transfer.
BmA and ES-62 do not alter DCmaturation
In previous studies both BmA [50] and ES-62 [34,35] have been shown to modulate murine
macrophage and/or DC responses. Here we examined whether BmA or ES-62 were capable of
inducing, facilitating or altering human DCmaturation in the context of co-stimulatory mole-
cules as well as cytokine production. To this end, DCs were matured under optimal conditions
(100ng/ml LPS) and suboptimal conditions (1ng/ml LPS) in the presence of 10, 25 or 75μg/ml
BmA. We demonstrate that the addition of BmA does not alter the cells capacity to upregulate
co-stimulatory molecules CD86, CD83 and HLA-DR, whether the cells are matured under sub-
optimal or optimal conditions by expressing the geometric mean found in conditions with BmA
as a relative in- or de-crease compared to the LPS control condition (Fig 2A–2C). Similarly,
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when maturing iDCs in the presence of 100ng/ml LPS and 1, 2 or 4μg/ml ES-62 we also did not
observe differences in the level of CD86, CD83 or HLA-DR compared to the LPS control condi-
tion (Fig 2D and 2E). Furthermore, BmA and ES-62 could not upregulate CD86, CD83 or
HLA-DR on iDCs (S2 Fig).
Fig 1. BmA inhibits HIV-1 trans-infection but not cis-infection whereas ES-62 does not affect either. The effect of 1, 5 and 25μg/ml BmA (A) and 1, 2
and 4μg/ml ES-62 (B) on HIV-1 SF162 (R5) and LAI (X4) cis-infection of CD4+ enriched T-cells determined by viral outgrowth (supernatant p24 levels). (C)
BmA (max. 25μg/ml) was coated on to an ELISA plate after which DC-SIGN-Fc binding was determined (DC-SIGN binding ELISA). The highest OD was set
to 100% binding demonstrating a dose-response curve. (D) The capacity of DC-SIGN-Fc, pre-incubated with BmA (max. 50μg/ml) or mannan (max. 50μg/
ml), to bind a gp140 coated ELISA plate was determined (gp140 competition ELISA). The highest OD was set to 100% implying that 0.001μg/ml of BmA and
mannan do not block DC-SIGN-Fc binding to gp140. (E) Raji-DC-SIGN cells were incubated with 5μg/ml BmA before addition of SF162 (R5) or LAI (X4).
Subsequently viral outgrowth (supernatant p24 levels) was monitored in Raji DC-SIGN-CD4+ enriched T-cells co-cultures. (A-E) Representative experiment
shown where all data points were performed in triplicate and with each experiment performed at least 3 times (* p<0.05). (F) iDCs were incubated with
medium or 500μg/ml BmA before washing and the addition of SF162 (R5). Viral outgrowth (supernatant p24 levels) was monitored in iDC-CD4+ enriched T-
cell co-cultures. Three donors were tested in duplicate and all results were combined (***p<0.001).
doi:10.1371/journal.pone.0146527.g001
Effects of Filarial Nematode Antigens on HIV-1 Infection
PLOS ONE | DOI:10.1371/journal.pone.0146527 January 25, 2016 7 / 18
Fig 2. BmA and ES-62 do not alter surface expression of co-stimulatory molecules or cytokine production. (A) The geometric mean of CD86 (white),
HLA-DR (grey) and CD83 (dark grey) on DCs exposed to 100ng/ml LPS and 10, 25 or 75μg/ml BmA expressed relative to the geometric mean found on cells
exposed to 100ng/ml LPS only. (B) A representative FACS plot demonstrating the expression of CD86 (left), CD83 (middle) and HLA-DR (right) on iDC
(grey), DC exposed to 100ng/ml LPS (black) and DC exposed to 100ng/ml LPS + 25μg/ml BmA (dashed). (C) The geometric mean of CD86 (white), HLA-DR
(grey) and CD83 (dark grey) on DCs exposed to 1ng/ml LPS and 10, 25 or 75μg/ml BmA expressed relative to the geometric mean found on cells exposed to
1ng/ml LPS only. (D) The geometric mean of CD86 (white), HLA-DR (grey) and CD83 (dark grey) on DCs exposed to 100ng/ml LPS and 1, 2 or 4μg/ml ES-62
expressed relative to the geometric mean found on cells exposed to 100ng/ml LPS only. (E) The geometric mean of CD86 (white), HLA-DR (grey) and CD83
(dark grey) on DCs exposed to 1ng/ml LPS and 1, 2 or 4μg/ml ES-62 expressed relative to the geometric mean found on cells exposed to 1ng/ml LPS only.
Effects of Filarial Nematode Antigens on HIV-1 Infection
PLOS ONE | DOI:10.1371/journal.pone.0146527 January 25, 2016 8 / 18
To determine effects on cytokine production, iDC were exposed to 10, 25 or 75μg/ml BmA
in absence or presence of 100ng/ml LPS. The supernatant was analyzed for IL-6, IL-10, IL-12
and TNF-α. IL-6, IL-10 and TNF-α were only produced when cells were stimulated with
100ng/ml LPS and the amount produced, 1.5ng/ml, 0.6ng/ml and 0.9ng/ml respectively was
not affected by the presence of 10, 25 or 75μg/ml BmA (Fig 2G). Similarly, 1, 2 or 4μg/ml ES-
62 did not affect the amount of IL-6, IL-10 and TNF-α that was produced (Fig 2F). IL-12 was
not produced to detectable amounts in any condition (data not shown). Collectively our data
suggest that neither BmA nor ES-62 can alter LPS induced up-regulation of co-stimulatory
molecules or alter cytokine production.
BmA-exposed DCs do not induce Th-cells with an altered susceptibility
to HIV-1
Although BmA and ES-62 do not alter DC maturation described above there are other factors
that can influence the T-cell outgrowth in DC-T-cell co-cultures which potentially alters T-cell
HIV-1 susceptibility. For instance, the level of T-cell activation has been associated with the
number of HIV-1 restriction factors that are up regulated [20]. In order to determine whether
the HIV-1 susceptibility of Th-cells induced by DCs exposed to BmA or ES-62 is altered, we
established an in vitro cell system. Here iDCs were matured in Th1/Th2 mixed (LPS) or Th2
(LPS+ PgE2) promoting conditions in the absence or presence of BmA or ES-62. Co-culturing
mature Staphylococcus Enterotoxin B-loaded DCs from donor A with naïve CD4+CD45RA+
T-cells from donor B for 8 days resulted in the respective Th-cell cultures, which were subse-
quently infected with HIV-1 SF162 (R5) or LAI (X4). Here we focussed on the effect of BmA
on Th1/Th2 mixed (Tmix) and Th2 cell cultures as these are expected to be preferentially modu-
lated by parasite extracts. In the Tmix and Th2 cell cultures induced by unexposed DCs we
found on average 3.8% ±0.82 and 6.1% ±2.3 SF162 (R5) infected T-cells respectively (p = 0.36)
(Fig 3A). Similar percentages of SF162 (R5) infected cells were observed in Tmix and Th2 cell
cultures induced by BmA exposed DCs, 4.4% ±1.0 and 5.4% ±1.9 respectively (p = 0.66) (Fig
3B). To determine whether BmA affected SF162 (R5) susceptibility of T-cell cultures, we
expressed the percentage of SF162+ T-cells induced by BmA exposed DCs relative to the per-
centage of SF162+ T-cells in cultures induced by unexposed DCs (set at 1.0). This revealed that
both in Tmix and Th2 cell cultures the level of SF162 (R5) infection is similar, p = 0.39 and
p = 0.63, respectively (Fig 3C).
In LAI (X4) infected Tmix and Th2 cell cultures we find on average similar percentages of
LAI+ cells 23.1% ±7.1 and 23.5% ±6.7, respectively (p = 0.97), when these cultures were
induced by unexposed DCs and 26.0% ±5.8 and 22.7 ±8.8 LAI+ cells, respectively (p = 0.77),
when induced by BmA-exposed DCs (Fig 3D and 3E). Again, when we express the level of
infection found in T-cell cultures induced by BmA-exposed DCs relative to the level of infec-
tion in T-cell cultures induced by unexposed DCs we found that the level of infection is similar
in Tmix and Th2 cell population, p = 0.08 and p = 0.31, respectively (Fig 3F). The difference in
the level of infection obtained by SF162 (R5) and LAI (X4) can be explained by the difference
in efficiency by which R5 and X4 HIV-1 viruses infect CD4+ T-cells in vitro [51]. Collectively,
our data demonstrate that exposing DCs to BmA does not result in T-cell cultures with an
altered susceptibility to HIV-1 infection.
IL6 (left), IL10 (middle) and TNFα (right) cytokine production by DCs exposed to 100ng/ml LPS and 4μg/ml ES-62 (F) or 100ng/ml LPS and 75μg/ml BmA (G).
(A, C-E) Data of three independent experiments combined (mean and SD), (F andG) representative of 2 independent experiments performed in triplicate.
doi:10.1371/journal.pone.0146527.g002
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Th-cell cultures induced by BmA- or ES-62 exposed DCs do not have a
more pronounced Th2 phenotype
As B.malayi infection has been previously shown to skew T-cell responses towards a Th2 cell
profile in a murine model, we evaluated the cytokine/chemokine (IFN-γ, IL-4, IL-2, TNF-α,
MIP-1β) profile of the Th-cell cultures induced by BmA exposed DCs [52]. All cells produced
IL-2 and TNF-α under all circumstances (data not shown).
First we demonstrated that HIV-1 SF162 (R5) or LAI (X4) infection did not influence the
capacity of the Th-cells to produce IFN-γ, MIP-1β or IL-4 (Fig 4A). Subsequently, we deter-
mined the effect of exposing DCs to 25μg/ml BmA on the capacity of the induced Th-cell cul-
tures to produce IFN-γ, IL-4 and MIP-1β. Both in Tmix and Th2 cultures we did not find
differences in the level of IFN-γ, IL-4 and MIP-1β when BmA was added to maturing DCs (Fig
4B). Even when the BmA concentration that DCs were exposed to was increased to 75μg/ml no
effect on the percentage of cells producing IFN-γ, IL-4 and MIP-1β in the induced Tmix cell cul-
tures was observed (Fig 4C).
Similarly, DCs exposed to ES-62 did not induce T-cell cultures that have an altered cyto-
kine/chemokine profile (Fig 5A). Moreover, as with BmA, ES-62 exposed DCs do not alter the
Fig 3. Exposing DCs to BmA does not alter the HIV-1 susceptibility of the induced Th-cell population. (A, D) Percentage SF162+ (A) or LAI+ (D) cells
in Tmix and Th2 cell cultures induced by unexposed DCs. (B, E) Percentage SF162
+ (B) or LAI+ (E) cells in Tmix and Th2 cell cultures induced by BmA
exposed DCs. (C, F) The relative expression of SF162+ (C) and LAI+ (F) in Tmix and Th2 cell cultures induced by BmA exposed DCs compared to the
expression in Th-cell cultures induced unexposed DC. (A-F) Depicted are mean values and SEM of 5 independent experiments using 5 different DC-T cell
donor combinations.
doi:10.1371/journal.pone.0146527.g003
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T-cells capacity to support HIV-1 infection. The average percentage of SF162+ T-cells were
very similar in cultures induced by unexposed or ES-62 exposed DCs, 5.7% ± 2.8 and 5.8%
±2.9 respectively (Fig 5B) and no effect of ES-62 on the percentage of infected T-cells was
observed (p = 0.97, Fig 5D left). The average percentage of LAI+ T-cells in Th2 cultures induced
by unexposed DCs was slightly higher, 30% ±4.3 than the percentage found in Th2 cultures
induced by ES-62-exposed DCs, 22.2% ±7.6 (p = 0.39) (Fig 5C). However, even when deter-
mining the relative difference between the percentage of LAI+ cells in cultures induced by
unexposed versus ES-62 exposed DCs no significance was found (p = 0.22) (Fig 5D right). In
summary, both BmA and ES-62 exposed DCs do not induce Th2 skewing in our model system,
potentially explaining why HIV-1 infection is unaffected in the T-cell cultures induced by DCs
exposed to the parasite extract.
Fig 4. Exposure of DCs to BmA does not alter Th-cell cytokine/chemokine expression profiles. (A) Percentage of IFNγ, MIP-1β and IL-4 producing T-
cells in uninfected (1st bar), SF162 (R5) (2nd bar) or LAI (X4) (3rd bar) infected Th-cell cultures. The figure is representative for both Tmix and Th2 cell cultures.
(B) Percentage of IFNγ, MIP-1β and IL-4 producing T-cells in a Tmix (upper figure) and a Th2 (lower figure) cell culture induced by DCs unexposed (1
st, 3rd, 5th
bar) or exposed to 25μg/ml BmA (2nd, 4th, 6th bar). (C) IFNγ, MIP-1β and IL-4 producing T-cells in a Tmix cell culture induced by DCs unexposed or exposed to
75μg/ml BmA. (A-C) Representative figure of an experiment performed at least 3 times in (A) the conditions where virus was added were performed in
duplicate.
doi:10.1371/journal.pone.0146527.g004
Effects of Filarial Nematode Antigens on HIV-1 Infection
PLOS ONE | DOI:10.1371/journal.pone.0146527 January 25, 2016 11 / 18
Discussion
Parasitic helminths have co-evolved with the human host for millions of years during which
they have acquired immunomodulatory properties. Here we aimed to determine whether BmA
from adult B.malayi and ES-62 from A. viteae had immunomodulatory properties that influ-
ence HIV-1 infection. We demonstrate that BmA, but not ES-62, can potently bind DC-SIGN
and inhibit HIV-1 trans-infection of CD4+ enriched T-cells, whilst neither antigen can block
cis-infection. We identified using an in vitro DC-T-cell outgrowth assay that neither BmA nor
ES-62 had the capacity to modulate DC maturation (CD86, CD83, HLA-DR, IL-6, IL-10, IL-12
and TNF-α) or the phenotype of the induced of Th-cells (IFN-γ, IL-4 and MIP-1β). In addi-
tion, the HIV-1 susceptibility of the Th-cells induced by DCs exposed to either BmA or ES-62
remained unaltered.
The major studies performed to date regarding altered responses of antigen presenting cells
and subsequent Th2 skewing by BmA have been performed in mouse model systems. One
study demonstrates that adherent peritoneal exudate cells (PEC), isolated from mice that had 6
Fig 5. Exposing DCs to ES-62 does not alter the HIV-1 susceptibility of the induced Th-cell population nor their cytokine/chemokine profiles. (A)
Percentage of IFN-γ, IL-4 and MIP-1β producing T cells in Th2 cell cultures induced by DCs unexposed or exposed to 2–4μg/ml ES-62. (B) Percentage
SF162+ T-cells found in Th2 cell cultures induced by unexposed DCs (left) or DCs exposed to 2–4μg/ml ES-62 (right). (C) Percentage LAI+ T-cells found in
Th2 cell cultures induced by unexposed DCs (left) or DCs exposed to 2–4μg/ml ES-62 (right). (D) The relative level of SF162 (R5) (left) and LAI (X4) infection
(right) in Th2 cultures induced by DCs exposed to 2–4μg/ml ES-62 compared to the level found in Th2 cell cultures induced by unexposed DCs. (A) A
representative figure of an experiment performed at least 3 times; (B-D) mean values and SEM of 4 independent experiments using 4 different DC-T cell
donor combinations.
doi:10.1371/journal.pone.0146527.g005
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adult female B.malayi worms intra-peritoneally implanted, have the capacity to induce Th2
cell responses when co-cultured with naïve T-cells [52]. Approximately 80% of PEC is com-
posed of macrophages suggesting that they are the cell type responsible for Th2 skewing in this
system whereas we used DCs [52,53]. Another study demonstrates the capacity of BmA to
induce TNF-α, IL-1β and nitric oxide (NO) production by murine macrophages in a TLR4
dependent manner [50]. These effects were attributed to the presence of a LPS-like molecule
derived from the intracellular bacteriumWolbachia that plays an essential role in the survival
and fertility of filarial nematodes. Human filarial nematodes are infected withWolbachia whilst
A. viteae is not. Indeed A. viteae lysates could not induce cytokine or NO production by murine
macrophages [3,50,54]. The potency ofWolbachia in altering human immune responses was
emphasized by a recent study which demonstrated that the major surface component ofWol-
bachia in filarial nematodes can signal through TLR2 and TLR4 thereby inducing cytokine pro-
duction in human embryonic kidney cells, primary murine macrophages and DCs as well as
human PBMCs [55]. When we examined our BmA batch for the presence of LPS or an LPS-
like molecule using a Limulus amebocyte lysate (LAL) assay we found it did not contain such a
molecule (data not shown), thereby contributing to an explanation for the lack of changes to
iDC, maturing DCs and the subsequently induced Th-cell populations. It should be noted that
mice do not express DC-SIGN but eight homologues of which the SIGNR family resembles
DC-SIGN most closely. However, thus far no homologue with similar glycan recognition, sig-
naling and cell distribution as DC-SIGN has been identified in mice, providing another poten-
tial explanation for the discrepancy between our human data and reported mouse data [56]. It
has also been demonstrated that PBMCs from patients with pathological lymphedema show
enhanced transendothelial migration when stimulated with BmA compared to PBMCs from
patients with an asymptomatic filarial nematode infection indicating another potential BmA
mediated mechanism of immune-pathology [57].
A less complex explanation for the inability of BmA to alter DC maturation is that the com-
ponents involved in these processes are present in different stages of the B.malayi life cycle.
Although it has been shown that the female adult worm in particular was involved in inducing
Th2 cell responses [26], a study by Semnani et al. revealed that the microfilaria (mf) L1 larvae
can induce IL-6 and TNF-α production while impairing IL-10 and IL-12 production by human
DCs [58]. Additionally, recent studies on the secretome of B.malayi compared the excretory
secretory (ES) fractions with homogenized adult worm (BmA) and found that the ES fractions
contained much higher levels of the PC-containing components which are known to have
many immunomodulatory properties [28]. Therefore, the concentration of the immunomodu-
latory components in BmA may be too low rather than that the adult worm is not capable of
altering DC maturation and subsequent Th-cell induction. Nevertheless, ES-62 is a purified
glycoprotein containing PC groups and this molecule neither altered DC maturation nor Th-
cell induction in our DC-T-cell outgrowth model.
ES-62 derived from the rodent filarial nematode A. viteae has been well studied. In mouse
model systems it has been shown to alter DC maturation, induce Th2 cell responses and reduce
the severity of numerous auto-immune diseases [29,31–39]. However, one study on human
primary mast cells demonstrated that FcεRI receptor responses were inhibited by ES-62 follow-
ing its complexing with TLR4, which resulted in protein kinase C-α sequestration and degrada-
tion [41]. Additionally, ES-62 can inhibit pro-inflammatory cytokine production in synovial
membranes and fluid from patients with rheumatoid arthritis (ex vivo) which is driven by mac-
rophages [45]. Our data indicate that ES-62 has no effect on modulating human DC responses
nor the Th-cell phenotype they induce which suggests that the product can be used for other
immunomodulatory activities without affecting T-cell skewing or modulating viral replication
in HIV-1 infected individuals. Albeit, we cannot exclude the possibility that our experimental
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set up may not have been optimal to detect the effect of ES-62. Previous studies have demon-
strated that the effect of ES-62 is biphasic with initially a small activating effect observed fol-
lowed by inertia for subsequent stimuli [59]. In our system, ES-62 was added simultaneous
with the LPS stimulus, which potentially prevented ES-62 from inducing inertia despite the
long incubation period (48 hours).
The active components of the glycoprotein ES-62 are the attached PC groups. Some studies
in mice have demonstrated that proteins with coupled PC mimicked the results obtained by
addition of ES-62 [42,43,60]. PC is not unique to parasitic helminths and is present on many
different pathogens where it appears to play an important role in their survival [61]. As for the
interaction of PC with the human immune system there is very limited evidence that the exten-
sive effects found in rodents can be directly translated to humans. There are some examples
described in the literature where molecules containing PC groups, which have immunomodu-
latory properties similar to those seen with ES-62. However, it is still unclear as to whether
these effects can be attributed to the presence of the PC group. For example, the lyso-sphingoli-
pid sphingosylphosphorylcholine (SPC) found in high density lipoproteins is capable of up-
regulating CD86, CD83 and HLA-DR on human DCs as well as inducing the production of IL-
12 and IL-18 [62]. Secondly, oxidized 1-palmitoyl-2-arachidoyl-sn-glycero-3-phosphorylcho-
line (OxPAPC) has been shown to bind TLR4 thereby inhibiting DC maturation with LPS, as
measured by up-regulation of co-stimulatory molecules CD86, CD83, HLA-DR and several
others [63]. Remarkably only the oxidized form of PAPC possessed this capacity indicating
that potentially not all effects are due to the PC group [63]. Lastly, miltefosin, a phosphorylcho-
line esther of hexadecanol is a medicine used for the treatment of visceral leishmaniasis in
HIV-1 co-infected individuals which has been shown to reduce HIV-1 replication in CD4+ T-
cells that was, in part, caused by the onset of IFN type I production by DCs [64]. These diver-
gent results suggest that in humans probably the context in which the PC group is present is
important for the subsequent elicited immune responses.
From epidemiological data and studies using human material it is still relatively unknown
what effects filarial nematodes will have on HIV-1 infection in vivo. One study demonstrates
that the prevalence ofW. bancrofti in HIV-1-infected and uninfected individuals is similar [65]
while another study by Gallagher et al. found that HIV-1+ women were more likely to be co-
infected with a filarial nematode. Since HIV-1 infection via sexual transmission is acquired
later in life than lymphatic filariasis Gallagher et al. speculated that filarial nematode infections
result in an increased susceptibility to HIV-1 infection [66]. Additionally, a study by Nielsen
et al. demonstrated that the HIV-1 viral load, CD4+ cell percentage and CD4+/CD8+ cell ratio
was similar in HIV-1+ and HIV-1+ W. bancrofti+ individuals [67] while a study by Gopinath
et al. found that CD8+-depleted PBMCs from patients treated for lymphatic filariasis had a
reduced susceptibility to HIV-1 R5 viruses compared to CD8+-depleted PBMCs from the same
patients when they were untreated [68]. However, they also observed that the level of HIV-1
infection in CD8+-depleted PBMCs from healthy controls was similar to the level of infection
in cells from filarial nematode infected patients suggesting that the reduced level of infection is
induced by the treatment regimen rather than the death of the filarial nematodes [68]. Good in
vitromodel systems using human cells are therefore required to identify what role parasites
and their antigens have on modulating HIV-1 infection.
We have shown here that BmA can potently bind DC-SIGN and block HIV-1 trans-infec-
tion of CD4+ enriched T-cells and thereby potentially play a role in modulating HIV-1 infec-
tion or replication in exposed or infected individuals, respectively. This could be pertinent
given the presence of filarial nematodes within the afferent lymph vessels close to lymph nodes.
Once the DC-SIGN binding product has been identified it may be possible to speculate on the
physiological relevance of the concentrations we have used. Additionally, the patient’s worm
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load, which is highly variable, will likely be a major determinant in the concentration the
DC-SIGN binding component will reach in vivo. From the results obtained in our in vitro
DC-T-cell model system it seems that BmA and ES-62 do not induce beneficial, or more
importantly, undesirable effects on HIV-1 infection or replication of/in Th-cells induced by
DCs exposed to these parasite components. Determining the effects of other pathogen antigen
sources or antigens from other stages of B.malayi’s life-cycle on modulating immune responses
and affecting HIV-1 infection will provide a more complete picture in indicating what conse-
quences parasite co-infections have on modulating HIV-1 infection.
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S1 Fig. Both BmA and ES-62 are non-toxic for iDCs. Immature dendritic cells were exposed
to 100ng/ml LPS in combination with various concentrations of BmA (A) or ES62 (B) for 48h.
Subsequently the cells were analyzed by FACS. Depicted is the percentage of cells in the live-
gate.
(TIF)
S2 Fig. Neither BmA nor ES-62 induces co-stimulatory molecules on iDCs. (A) Depicted is
the expression of CD86 (left), CD83 (middle) and HLA-DR (right) on iDC (grey filled) and
iDC exposed to 10μg/ml (blue, dotted), 25μg/ml (red, dashed) or 75μg/ml BmA (black, solid).
(B) Depicted is the expression of CD86 (left), CD83 (middle) and HLA-DR (right) on iDC
(grey filled) and iDC exposed to 1μg/ml (blue, dotted), 2μg/ml (red, dashed) or 4μg/ml BmA
(black, solid).
(TIF)
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